ARVN FY 2017 Earnings — Arvinas, Inc. Revenue & Financial Results | Market Cap Arena

ARVNArvinas, Inc.

$856M

FY 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$8M+13.6% YoY

Gross Profit

$8M100.0% margin

Operating Income

-$25M-326.7% margin

Net Income

-$24M-317.3% margin

EPS (Diluted)

$-1.38

Cash Flow

Operating Cash Flow

$5M

Free Cash Flow

$4M

Stock-Based Comp.

$245,048

Balance Sheet

Total Assets

$67M

Total Liabilities

$67M

Stockholders' Equity

$245,870

Cash & Equivalents

$31M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$8M	$7M	+13.6%
Gross Profit	$8M	$7M	+13.6%
Operating Income	-$25M	-$16M	-50.3%
Net Income	-$24M	-$14M	-67.6%